Expertise in
9
conditions

Michael Joannidis

Innsbruck, AT 
Expertise in
9
conditions
Innsbruck, AT 
OverviewLocationsClinical Research

Overview

Michael Joannidis practices in Innsbruck, Austria. Mr. Joannidis is highly rated in 9 conditions, according to our data. His top areas of expertise are Sepsis, COVID-19, Severe Acute Respiratory Syndrome (SARS), Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH), and Kidney Transplant.

His clinical research consists of co-authoring 318 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years.

Gender
Male

Locations

Innsbruck, Austria
Other Locations
Tirol, Austria

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

Safety and Preliminary Efficacy of Sequential Multiple Ascending Doses of Solnatide to Treat Pulmonary Permeability Oedema in Patients With Moderate-to-severe ARDS - a Randomised, Placebo-controlled, Double-blind Trial
Safety and Preliminary Efficacy of Sequential Multiple Ascending Doses of Solnatide to Treat Pulmonary Permeability Oedema in Patients With Moderate-to-severe ARDS - a Randomised, Placebo-controlled, Double-blind Trial
Enrollment Status: Completed
Publish Date: May 14, 2025
Intervention Type: Drug
Study Phase: Phase 2
STandard Versus Accelerated Initiation of Renal Replacement Therapy in Acute Kidney Injury (STARRT-AKI): A Multi-Centre, Randomized, Controlled Trial (Principal Trial)
STandard Versus Accelerated Initiation of Renal Replacement Therapy in Acute Kidney Injury (STARRT-AKI): A Multi-Centre, Randomized, Controlled Trial (Principal Trial)
Enrollment Status: Completed
Publish Date: October 18, 2024
Intervention Type: Other
Study Phase: Not Applicable
REstricted Fluid Therapy VERsus Standard trEatment in Acute Kidney Injury - REVERSE-AKI Randomized Controlled Pilot Trial
REstricted Fluid Therapy VERsus Standard trEatment in Acute Kidney Injury - REVERSE-AKI Randomized Controlled Pilot Trial
Enrollment Status: Completed
Publish Date: December 14, 2020
Intervention Type: Other
Study Phase: Phase 2
A DB Four-Arm, Parallel Group, Proof of Concept, Dose-Finding Adaptive Phase 2a/2b RCT to Investigate the Safety, Tolerability and Efficacy and Effect on QoL of Human Recombinant Alkaline Phosphatase in Patients With Sepsis-Associated AKI
A DB Four-Arm, Parallel Group, Proof of Concept, Dose-Finding Adaptive Phase 2a/2b RCT to Investigate the Safety, Tolerability and Efficacy and Effect on QoL of Human Recombinant Alkaline Phosphatase in Patients With Sepsis-Associated AKI
Enrollment Status: Completed
Publish Date: March 23, 2020
Intervention Type: Other, Biological
Study Phase: Phase 2
View 3 Less Clinical Trials

318 Total Publications

Kidney-organ interactions: recent advances and clinical implications.
Kidney-organ interactions: recent advances and clinical implications.
Journal: Current opinion in critical care
Published: October 30, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Joannidis's expertise for a condition
ConditionClose
    View All 7 Advanced Conditions
    View All 28 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile